Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James P Allison

Showing results (21-30 of 226) with videos related to

Pageof 23
Sort By:
Oncoimmunology|July 4, 2012
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejectionRebecca Waitz, Marcella Fassò, James P Allison
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2019
TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletionNaveen Sharma, Jean Vacher, James P Allison
Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2011
Expression of Helios in peripherally induced Foxp3+ regulatory T cellsRachel A Gottschalk, Emily Corse, James P Allison
Nature|November 11, 2011
Nobels: Toll pioneers deserve recognitionJames P Allison, Christophe Benoist, Alexander V Chervonsky
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. 1982James P Allison, Bradley W McIntyre, David Bloch
Nature Immunology|December 22, 2005
Breaking down the barriers to cancer immunotherapyEllen Puré, James P Allison, Robert D Schreiber
Seminars in Oncology|March 27, 2007
Immunotherapeutic strategies for high-risk bladder cancerPadmanee Sharma, Lloyd J Old, James P Allison
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2011
Strength of TCR-peptide/MHC interactions and in vivo T cell responsesEmily Corse, Rachel A Gottschalk, James P Allison
The Journal of Experimental Medicine|July 28, 2010
TCR ligand density and affinity determine peripheral induction of Foxp3 in vivoRachel A Gottschalk, Emily Corse, James P Allison
Immunological Reviews|May 12, 2009
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infectionsTsvetelina Pentcheva-Hoang, Emily Corse, James P Allison
Pageof 23

Showing results (21-30 of 226) with videos related to

Sort By:
Pageof 23
Oncoimmunology|July 4, 2012
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejectionRebecca Waitz, Marcella Fassò, James P Allison
Proceedings of the National Academy of Sciences of the United States of America|May 12, 2019
TLR1/2 ligand enhances antitumor efficacy of CTLA-4 blockade by increasing intratumoral Treg depletionNaveen Sharma, Jean Vacher, James P Allison
Journal of Immunology (Baltimore, Md. : 1950)|December 27, 2011
Expression of Helios in peripherally induced Foxp3+ regulatory T cellsRachel A Gottschalk, Emily Corse, James P Allison
Nature|November 11, 2011
Nobels: Toll pioneers deserve recognitionJames P Allison, Christophe Benoist, Alexander V Chervonsky
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. 1982James P Allison, Bradley W McIntyre, David Bloch
Nature Immunology|December 22, 2005
Breaking down the barriers to cancer immunotherapyEllen Puré, James P Allison, Robert D Schreiber
Seminars in Oncology|March 27, 2007
Immunotherapeutic strategies for high-risk bladder cancerPadmanee Sharma, Lloyd J Old, James P Allison
Journal of Immunology (Baltimore, Md. : 1950)|April 21, 2011
Strength of TCR-peptide/MHC interactions and in vivo T cell responsesEmily Corse, Rachel A Gottschalk, James P Allison
The Journal of Experimental Medicine|July 28, 2010
TCR ligand density and affinity determine peripheral induction of Foxp3 in vivoRachel A Gottschalk, Emily Corse, James P Allison
Immunological Reviews|May 12, 2009
Negative regulators of T-cell activation: potential targets for therapeutic intervention in cancer, autoimmune disease, and persistent infectionsTsvetelina Pentcheva-Hoang, Emily Corse, James P Allison
Pageof 23